LB
Laura Brege sold $1.3M of MIRM stock
Laura Brege, Dir of Mirum Pharmaceuticals, Inc. (MIRM), sold 14,167 shares of MIRM stock worth $1.3M, per an SEC Form 4 filed Nov 13, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Nov 11, 2025, 367 days before it was made public.
MIRM has moved +31.8% since the trade date, from $71.32 to $93.99 (Nov 13, 2026 close).
- Traded
- Nov 11, 2025
- Disclosed
- Nov 13, 2026
- Filing delay
- 367 days
- Price since
- +31.8%
- Role
- Dir
- Source
- SEC Form 4